APTIMA
Device
Gen-Probe, Inc.
Total Payments
$8.9M
Transactions
31,773
Doctors
21,148
Companies
6
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.7M | 12,408 | 10,003 |
| 2023 | $6.6M | 8,996 | 7,020 |
| 2022 | $319,123 | 6,226 | 5,148 |
| 2021 | $172,237 | 4,099 | 3,580 |
| 2020 | $1,583 | 14 | 12 |
| 2019 | $4,567 | 4 | 3 |
| 2018 | $3,319 | 12 | 12 |
| 2017 | $1,211 | 14 | 14 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $6.5M | 281 | 73.1% |
| Consulting Fee | $1.3M | 241 | 14.9% |
| Food and Beverage | $800,003 | 30,646 | 9.0% |
| Travel and Lodging | $223,512 | 586 | 2.5% |
| Honoraria | $45,542 | 18 | 0.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,200 | 1 | 0.0% |
Payments by Type
Research
$6.5M
281 transactions
General
$2.4M
31,492 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A10940-SC2/FluP-CSP-02 | Gen-Probe, Inc. | $4.8M | 0 |
| Year 3: Surveillance for Mycoplasma genitalium in US Sexually Transmitted Disease (STD) Clinics | Gen-Probe, Inc. | $695,716 | 0 |
| 655-A10940-001 | Gen-Probe, Inc. | $299,086 | 0 |
| 670-P10936-001 | Gen-Probe, Inc. | $195,404 | 0 |
| A10960-SC2P-CSP-01 / A10960-SC2P-CSP-02 | Gen-Probe, Inc. | $147,509 | 0 |
| 655-A10960-001 | Gen-Probe, Inc. | $109,553 | 0 |
| The association of Mycoplasma genitalium and adverse perinatal outcomes in high-risk pregnant women | Gen-Probe, Inc. | $83,347 | 0 |
| Evaluation of the Aptima CMV Quant Assay in Plasma and Non-plasma samples | Gen-Probe, Inc. | $75,000 | 0 |
| TTIMS, HIV RNA in whole blood compared to plasma as reservoir parameter, EQAPOL, Replicate Aptima HIV assay testing, Biomarkers predicting time to viral rebound, | Gen-Probe, Inc. | $36,309 | 0 |
| Validation of Hologic-Developed Analyte Specific Reagents (ASR) for Detection of Genetic Markers of Macrolide Resistance in Mycoplasma genitalium | Gen-Probe, Inc. | $31,053 | 0 |
| Year 2: Surveillance for Mycoplasma genitalium in US Sexually Transmitted Disease (STD) Clinics | Gen-Probe, Inc. | $19,004 | 0 |
| TTIMS - Transfusion Transmissible Infection Monitoring System, HIV RNA in whole blood compared to plasma as reservoir parameter, EQAPOL, Replicate Aptima HIV assay testing, Biomarkers predicting time to viral rebound, | Gen-Probe, Inc. | $7,500 | 0 |
| A10810-ATVPS-CSP | Gen-Probe, Inc. | $1,800 | 0 |
Top Doctors Receiving Payments for APTIMA
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Seattle, WA | $6.5M | 281 |
| , MD | Anatomic Pathology | Las Vegas, NV | $285,901 | 277 |
| , MD | Maternal & Fetal Medicine | Albuquerque, NM | $207,735 | 33 |
| , MD | Obstetrics & Gynecology | Baltimore, MD | $172,522 | 242 |
| , M.D | Obstetrics & Gynecology | Nashua, NH | $126,029 | 82 |
| , M.D | Gynecology | Atlanta, GA | $102,488 | 47 |
| , MD | Pediatrics | San Francisco, CA | $78,356 | 45 |
| , M.D | Student in an Organized Health Care Education/Training Program | Princeton, NJ | $67,389 | 37 |
| , MD | Family Medicine | Columbia, SC | $56,035 | 25 |
| , WHNP | Women's Health | Saint Louis, MO | $50,601 | 40 |
| , MD | Obstetrics & Gynecology | Tucson, AZ | $49,019 | 36 |
| , MD | Anatomic Pathology & Clinical Pathology | Tampa, FL | $43,777 | 52 |
| , M.D | Obstetrics & Gynecology | West Bloomfield, MI | $42,507 | 23 |
| , CNM | Advanced Practice Midwife | Brookhaven, GA | $34,357 | 14 |
| , MD | Obstetrics & Gynecology | Woodbridge, VA | $33,071 | 8 |
| , MD | Infectious Disease | Birmingham, AL | $29,890 | 21 |
| , M.D | Maternal & Fetal Medicine | Silver Spring, MD | $29,184 | 7 |
| , M.D | Obstetrics & Gynecology | Durham, NC | $21,416 | 8 |
| , APRN, CNM | Advanced Practice Midwife | Carrollton, TX | $13,286 | 9 |
| , MD | Obstetrics & Gynecology | Oakland, CA | $10,899 | 5 |
| , MD | Obstetrics & Gynecology | Maumee, OH | $10,436 | 6 |
| , M.D | Anatomic Pathology & Clinical Pathology | Albuquerque, NM | $7,683 | 3 |
| , M.D | Sports Medicine | Franklin Lakes, NJ | $7,390 | 6 |
| , M.D | Surgery | Waxahachie, TX | $7,200 | 1 |
| , MD | Obstetrics & Gynecology | Loveland, CO | $6,443 | 2 |
Ad
Manufacturing Companies
- Gen-Probe, Inc. $7.8M
- Hologic Sales and Service, LLC $700,808
- Hologic, LLC $188,000
- Gen-Probe Sales & Service, Inc. $75,878
- HOLOGIC INC $44,950
- Cytyc Prenatal Products Corp. $8,000
Product Information
- Type Device
- Total Payments $8.9M
- Total Doctors 21,148
- Transactions 31,773
About APTIMA
APTIMA is a device associated with $8.9M in payments to 21,148 healthcare providers, recorded across 31,773 transactions in the CMS Open Payments database. The primary manufacturer is Gen-Probe, Inc..
Payment data is available from 2017 to 2024. In 2024, $1.7M was paid across 12,408 transactions to 10,003 doctors.
The most common payment nature for APTIMA is "Unspecified" ($6.5M, 73.1% of total).
APTIMA is associated with 13 research studies, including "A10940-SC2/FluP-CSP-02" ($4.8M).